This comprehensive analysis elucidates the genomic landscape of phyllodes tumors, highlights molecular markers corresponding to histologic grade, broadens the range of tumors with frequent MED12 mutations, and identifies IGF1R and EGFR as potential therapeutic targets in malignant phyllodes tumors [46]. This evidence concerns the gene MED12 and phyllodes tumor.